Hemodialysis Market By Product and Service (Equipments, Consumables, Drugs, Services), By Type (Conventional Hemodialysis, Daily Hemodialysis, Nocturnal Hemodialysis), By Dialysis Site (In-center dialysis, Home dialysis): Global Opportunity Analysis and I

Hemodialysis Market By Product and Service (Equipments, Consumables, Drugs, Services), By Type (Conventional Hemodialysis, Daily Hemodialysis, Nocturnal Hemodialysis), By Dialysis Site (In-center dialysis, Home dialysis): Global Opportunity Analysis and Industry Forecast, 2023-2032


The hemodialysis market was valued at $76.9 billion in 2022 and is estimated to reach $111.8 billion by 2032, exhibiting a CAGR of 3.8% from 2023 to 2032. Hemodialysis is a medical procedure used to remove waste from the blood of patients with chronic or acute kidney failure. The waste removal helps to maintain electrolyte balance in the patient’s body. The procedure works similar to an artificial kidney by filtering the blood through a device called the hemodialyzer. It also prevents accumulation of salts and wastes in blood, which is expected to lead to poisoning.

Major factors that drive the growth of the global hemodialysis market include rapid technological advancements in hemodialysis equipment, increase in geriatric population, and rise in incidence of renal diseases, especially end stage renal disease (ESRD). In addition, increase in funding for improved dialysis products and services, rise in incidence of diabetes and hypertension, and shortage of kidneys for transplantation are expected to further propel the market growth. However, complications and risks associated with the procedure of hemodialysis, such as severe anemia and fluid overload are expected to restrict the growth of the hemodialysis market. Moreover, surge in healthcare expenditure and unmet medical demands to get better treatment options in developing countries are anticipated to create lucrative opportunities for the expansion of the global market in the future. 

The hemodialysis market is segmented on the basis of product and service, type, and region. On the basis of product and service, the market is classified into equipment, consumables, drug, and services. The equipment segment is further bifurcated into dialysis machines, hemodialysis water treatment systems, and other hemodialysis equipment (hemodialysis chairs, body composition monitors, and various analysis systems). The consumables segment is bifurcated into dialyzers, catheters and needles, and other hemodialysis consumables (concentrates & solutions, dialysates, catheter end caps, cleaners). On the basis of type, the hemodialysis market is segregated into conventional hemodialysis, daily hemodialysis, and nocturnal hemodialysis. 

On the basis of dialysis site, the hemodialysis market is segregated into in-center dialysis and home dialysis. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA). 

The major players profiled in the report are Asahi Kasei Corporation, B. Braun Melsungen AG, Baxter International Inc., DaVita Inc., Diaverum, Fresenius Medical Care AG & Co. KGaA, Nikkiso Co., Ltd, Nipro Corporation, Rockwell Medical Technologies Inc., and TORAY INDUSTRIES, INC. (TORAY MEDICAL CO., LTD.). These major players have adopted acquisition, agreement, expansion, merger, partnership, product launch, product approval as key developmental strategy to improve the product portfolio of the hemodialysis market.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the hemodialysis market analysis from 2022 to 2032 to identify the prevailing hemodialysis market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the hemodialysis market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global hemodialysis market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Type

Conventional Hemodialysis
Daily Hemodialysis
Nocturnal Hemodialysis

By Dialysis Site

In-center dialysis
Home dialysis

By Product and Service

Consumables
Type
Dialyzers
Catheters
Other Hemodialysis Consumables
Equipments
Type
Dialysis Machines
Hemodialysis Water Treatment Systems
Others Hemodialysis Equipment
Drugs
Services

By Region

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA

Key Market Players

Baxter International Inc.
B. Braun Melsungen AG
Nipro Corporation
DaVita Inc.
Fresenius Medical Care AG & Co. KGaA
Diaverum Holding AB
Nikkiso Co., Ltd
TORAY INDUSTRIES, INC.
Asahi Kasei Corporation.
Rockwell Medical Technologies Inc.

Please Note: It will take 7-10 business days to complete the report upon order confirmation. 


CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Low bargaining power of suppliers
3.3.2. Low threat of new entrants
3.3.3. Low threat of substitutes
3.3.4. Low intensity of rivalry
3.3.5. Low bargaining power of buyers
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in prevalence of end stage renal disease (ESRD)
3.4.1.2. Rise in awareness regarding hemodialysis
3.4.1.3. Rise in incidence of diabetes and hypertension
3.4.1.4. Shortage of kidneys for transplantation
3.4.2. Restraints
3.4.2.1. Risks and complications associated with dialysis
3.4.3. Opportunities
3.4.3.1. Rise in adoption of key strategy
3.4.3.2. Growth opportunities in emerging economies
CHAPTER 4: HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE
4.1. Overview
4.1.1. Market size and forecast
4.2. Equipments
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.2.4. Equipments Hemodialysis Market by Type
4.3. Consumables
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.3.4. Consumables Hemodialysis Market by Type
4.4. Drugs
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
4.5. Services
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market share analysis by country
CHAPTER 5: HEMODIALYSIS MARKET, BY TYPE
5.1. Overview
5.1.1. Market size and forecast
5.2. Conventional Hemodialysis
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Daily Hemodialysis
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Nocturnal Hemodialysis
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
CHAPTER 6: HEMODIALYSIS MARKET, BY DIALYSIS SITE
6.1. Overview
6.1.1. Market size and forecast
6.2. In-center dialysis
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Home dialysis
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
CHAPTER 7: HEMODIALYSIS MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by Product and Service
7.2.3. Market size and forecast, by Type
7.2.4. Market size and forecast, by Dialysis Site
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Market size and forecast, by Product and Service
7.2.5.1.2. Market size and forecast, by Type
7.2.5.1.3. Market size and forecast, by Dialysis Site
7.2.5.2. Canada
7.2.5.2.1. Market size and forecast, by Product and Service
7.2.5.2.2. Market size and forecast, by Type
7.2.5.2.3. Market size and forecast, by Dialysis Site
7.2.5.3. Mexico
7.2.5.3.1. Market size and forecast, by Product and Service
7.2.5.3.2. Market size and forecast, by Type
7.2.5.3.3. Market size and forecast, by Dialysis Site
7.3. Europe
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by Product and Service
7.3.3. Market size and forecast, by Type
7.3.4. Market size and forecast, by Dialysis Site
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Market size and forecast, by Product and Service
7.3.5.1.2. Market size and forecast, by Type
7.3.5.1.3. Market size and forecast, by Dialysis Site
7.3.5.2. France
7.3.5.2.1. Market size and forecast, by Product and Service
7.3.5.2.2. Market size and forecast, by Type
7.3.5.2.3. Market size and forecast, by Dialysis Site
7.3.5.3. UK
7.3.5.3.1. Market size and forecast, by Product and Service
7.3.5.3.2. Market size and forecast, by Type
7.3.5.3.3. Market size and forecast, by Dialysis Site
7.3.5.4. Italy
7.3.5.4.1. Market size and forecast, by Product and Service
7.3.5.4.2. Market size and forecast, by Type
7.3.5.4.3. Market size and forecast, by Dialysis Site
7.3.5.5. Spain
7.3.5.5.1. Market size and forecast, by Product and Service
7.3.5.5.2. Market size and forecast, by Type
7.3.5.5.3. Market size and forecast, by Dialysis Site
7.3.5.6. Rest of Europe
7.3.5.6.1. Market size and forecast, by Product and Service
7.3.5.6.2. Market size and forecast, by Type
7.3.5.6.3. Market size and forecast, by Dialysis Site
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by Product and Service
7.4.3. Market size and forecast, by Type
7.4.4. Market size and forecast, by Dialysis Site
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Market size and forecast, by Product and Service
7.4.5.1.2. Market size and forecast, by Type
7.4.5.1.3. Market size and forecast, by Dialysis Site
7.4.5.2. China
7.4.5.2.1. Market size and forecast, by Product and Service
7.4.5.2.2. Market size and forecast, by Type
7.4.5.2.3. Market size and forecast, by Dialysis Site
7.4.5.3. Australia
7.4.5.3.1. Market size and forecast, by Product and Service
7.4.5.3.2. Market size and forecast, by Type
7.4.5.3.3. Market size and forecast, by Dialysis Site
7.4.5.4. India
7.4.5.4.1. Market size and forecast, by Product and Service
7.4.5.4.2. Market size and forecast, by Type
7.4.5.4.3. Market size and forecast, by Dialysis Site
7.4.5.5. South Korea
7.4.5.5.1. Market size and forecast, by Product and Service
7.4.5.5.2. Market size and forecast, by Type
7.4.5.5.3. Market size and forecast, by Dialysis Site
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Market size and forecast, by Product and Service
7.4.5.6.2. Market size and forecast, by Type
7.4.5.6.3. Market size and forecast, by Dialysis Site
7.5. LAMEA
7.5.1. Key market trends, growth factors and opportunities
7.5.2. Market size and forecast, by Product and Service
7.5.3. Market size and forecast, by Type
7.5.4. Market size and forecast, by Dialysis Site
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Market size and forecast, by Product and Service
7.5.5.1.2. Market size and forecast, by Type
7.5.5.1.3. Market size and forecast, by Dialysis Site
7.5.5.2. Saudi Arabia
7.5.5.2.1. Market size and forecast, by Product and Service
7.5.5.2.2. Market size and forecast, by Type
7.5.5.2.3. Market size and forecast, by Dialysis Site
7.5.5.3. South Africa
7.5.5.3.1. Market size and forecast, by Product and Service
7.5.5.3.2. Market size and forecast, by Type
7.5.5.3.3. Market size and forecast, by Dialysis Site
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Market size and forecast, by Product and Service
7.5.5.4.2. Market size and forecast, by Type
7.5.5.4.3. Market size and forecast, by Dialysis Site
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product mapping of top 10 player
8.4. Competitive dashboard
8.5. Competitive heatmap
8.6. Top player positioning, 2022
CHAPTER 9: COMPANY PROFILES
9.1. Baxter International Inc.
9.1.1. Company overview
9.1.2. Key executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. Business performance
9.1.7. Key strategic moves and developments
9.2. B. Braun Melsungen AG
9.2.1. Company overview
9.2.2. Key executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.2.6. Business performance
9.2.7. Key strategic moves and developments
9.3. Asahi Kasei Corporation.
9.3.1. Company overview
9.3.2. Key executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.3.6. Business performance
9.4. DaVita Inc.
9.4.1. Company overview
9.4.2. Key executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.4.6. Business performance
9.4.7. Key strategic moves and developments
9.5. Nikkiso Co., Ltd
9.5.1. Company overview
9.5.2. Key executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.5.6. Business performance
9.6. Nipro Corporation
9.6.1. Company overview
9.6.2. Key executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.6.6. Business performance
9.6.7. Key strategic moves and developments
9.7. Fresenius Medical Care AG & Co. KGaA
9.7.1. Company overview
9.7.2. Key executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.7.6. Business performance
9.7.7. Key strategic moves and developments
9.8. Diaverum Holding AB
9.8.1. Company overview
9.8.2. Key executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.8.6. Key strategic moves and developments
9.9. Rockwell Medical Technologies Inc.
9.9.1. Company overview
9.9.2. Key executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.9.6. Business performance
9.9.7. Key strategic moves and developments
9.10. TORAY INDUSTRIES, INC.
9.10.1. Company overview
9.10.2. Key executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
9.10.6. Business performance
9.10.7. Key strategic moves and developments
LIST OF TABLES
TABLE 01. GLOBAL HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
TABLE 02. HEMODIALYSIS MARKET FOR EQUIPMENTS, BY REGION, 2022-2032 ($MILLION)
TABLE 03. GLOBAL EQUIPMENTS HEMODIALYSIS MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 04. HEMODIALYSIS MARKET FOR CONSUMABLES, BY REGION, 2022-2032 ($MILLION)
TABLE 05. GLOBAL CONSUMABLES HEMODIALYSIS MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 06. HEMODIALYSIS MARKET FOR DRUGS, BY REGION, 2022-2032 ($MILLION)
TABLE 07. HEMODIALYSIS MARKET FOR SERVICES, BY REGION, 2022-2032 ($MILLION)
TABLE 08. GLOBAL HEMODIALYSIS MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 09. HEMODIALYSIS MARKET FOR CONVENTIONAL HEMODIALYSIS, BY REGION, 2022-2032 ($MILLION)
TABLE 10. HEMODIALYSIS MARKET FOR DAILY HEMODIALYSIS, BY REGION, 2022-2032 ($MILLION)
TABLE 11. HEMODIALYSIS MARKET FOR NOCTURNAL HEMODIALYSIS, BY REGION, 2022-2032 ($MILLION)
TABLE 12. GLOBAL HEMODIALYSIS MARKET, BY DIALYSIS SITE, 2022-2032 ($MILLION)
TABLE 13. HEMODIALYSIS MARKET FOR IN-CENTER DIALYSIS, BY REGION, 2022-2032 ($MILLION)
TABLE 14. HEMODIALYSIS MARKET FOR HOME DIALYSIS, BY REGION, 2022-2032 ($MILLION)
TABLE 15. HEMODIALYSIS MARKET, BY REGION, 2022-2032 ($MILLION)
TABLE 16. NORTH AMERICA HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
TABLE 17. NORTH AMERICA HEMODIALYSIS MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 18. NORTH AMERICA HEMODIALYSIS MARKET, BY DIALYSIS SITE, 2022-2032 ($MILLION)
TABLE 19. NORTH AMERICA HEMODIALYSIS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 20. U.S. HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
TABLE 21. U.S. HEMODIALYSIS MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 22. U.S. HEMODIALYSIS MARKET, BY DIALYSIS SITE, 2022-2032 ($MILLION)
TABLE 23. CANADA HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
TABLE 24. CANADA HEMODIALYSIS MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 25. CANADA HEMODIALYSIS MARKET, BY DIALYSIS SITE, 2022-2032 ($MILLION)
TABLE 26. MEXICO HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
TABLE 27. MEXICO HEMODIALYSIS MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 28. MEXICO HEMODIALYSIS MARKET, BY DIALYSIS SITE, 2022-2032 ($MILLION)
TABLE 29. EUROPE HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
TABLE 30. EUROPE HEMODIALYSIS MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 31. EUROPE HEMODIALYSIS MARKET, BY DIALYSIS SITE, 2022-2032 ($MILLION)
TABLE 32. EUROPE HEMODIALYSIS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 33. GERMANY HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
TABLE 34. GERMANY HEMODIALYSIS MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 35. GERMANY HEMODIALYSIS MARKET, BY DIALYSIS SITE, 2022-2032 ($MILLION)
TABLE 36. FRANCE HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
TABLE 37. FRANCE HEMODIALYSIS MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 38. FRANCE HEMODIALYSIS MARKET, BY DIALYSIS SITE, 2022-2032 ($MILLION)
TABLE 39. UK HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
TABLE 40. UK HEMODIALYSIS MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 41. UK HEMODIALYSIS MARKET, BY DIALYSIS SITE, 2022-2032 ($MILLION)
TABLE 42. ITALY HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
TABLE 43. ITALY HEMODIALYSIS MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 44. ITALY HEMODIALYSIS MARKET, BY DIALYSIS SITE, 2022-2032 ($MILLION)
TABLE 45. SPAIN HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
TABLE 46. SPAIN HEMODIALYSIS MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 47. SPAIN HEMODIALYSIS MARKET, BY DIALYSIS SITE, 2022-2032 ($MILLION)
TABLE 48. REST OF EUROPE HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
TABLE 49. REST OF EUROPE HEMODIALYSIS MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 50. REST OF EUROPE HEMODIALYSIS MARKET, BY DIALYSIS SITE, 2022-2032 ($MILLION)
TABLE 51. ASIA-PACIFIC HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
TABLE 52. ASIA-PACIFIC HEMODIALYSIS MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 53. ASIA-PACIFIC HEMODIALYSIS MARKET, BY DIALYSIS SITE, 2022-2032 ($MILLION)
TABLE 54. ASIA-PACIFIC HEMODIALYSIS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 55. JAPAN HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
TABLE 56. JAPAN HEMODIALYSIS MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 57. JAPAN HEMODIALYSIS MARKET, BY DIALYSIS SITE, 2022-2032 ($MILLION)
TABLE 58. CHINA HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
TABLE 59. CHINA HEMODIALYSIS MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 60. CHINA HEMODIALYSIS MARKET, BY DIALYSIS SITE, 2022-2032 ($MILLION)
TABLE 61. AUSTRALIA HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
TABLE 62. AUSTRALIA HEMODIALYSIS MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 63. AUSTRALIA HEMODIALYSIS MARKET, BY DIALYSIS SITE, 2022-2032 ($MILLION)
TABLE 64. INDIA HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
TABLE 65. INDIA HEMODIALYSIS MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 66. INDIA HEMODIALYSIS MARKET, BY DIALYSIS SITE, 2022-2032 ($MILLION)
TABLE 67. SOUTH KOREA HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
TABLE 68. SOUTH KOREA HEMODIALYSIS MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 69. SOUTH KOREA HEMODIALYSIS MARKET, BY DIALYSIS SITE, 2022-2032 ($MILLION)
TABLE 70. REST OF ASIA-PACIFIC HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
TABLE 71. REST OF ASIA-PACIFIC HEMODIALYSIS MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 72. REST OF ASIA-PACIFIC HEMODIALYSIS MARKET, BY DIALYSIS SITE, 2022-2032 ($MILLION)
TABLE 73. LAMEA HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
TABLE 74. LAMEA HEMODIALYSIS MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 75. LAMEA HEMODIALYSIS MARKET, BY DIALYSIS SITE, 2022-2032 ($MILLION)
TABLE 76. LAMEA HEMODIALYSIS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 77. BRAZIL HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
TABLE 78. BRAZIL HEMODIALYSIS MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 79. BRAZIL HEMODIALYSIS MARKET, BY DIALYSIS SITE, 2022-2032 ($MILLION)
TABLE 80. SAUDI ARABIA HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
TABLE 81. SAUDI ARABIA HEMODIALYSIS MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 82. SAUDI ARABIA HEMODIALYSIS MARKET, BY DIALYSIS SITE, 2022-2032 ($MILLION)
TABLE 83. SOUTH AFRICA HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
TABLE 84. SOUTH AFRICA HEMODIALYSIS MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 85. SOUTH AFRICA HEMODIALYSIS MARKET, BY DIALYSIS SITE, 2022-2032 ($MILLION)
TABLE 86. REST OF LAMEA HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
TABLE 87. REST OF LAMEA HEMODIALYSIS MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 88. REST OF LAMEA HEMODIALYSIS MARKET, BY DIALYSIS SITE, 2022-2032 ($MILLION)
TABLE 89. BAXTER INTERNATIONAL INC.: KEY EXECUTIVES
TABLE 90. BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT
TABLE 91. BAXTER INTERNATIONAL INC.: PRODUCT SEGMENTS
TABLE 92. BAXTER INTERNATIONAL INC.: PRODUCT PORTFOLIO
TABLE 93. BAXTER INTERNATIONAL INC.: KEY STRATERGIES
TABLE 94. B. BRAUN MELSUNGEN AG: KEY EXECUTIVES
TABLE 95. B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
TABLE 96. B. BRAUN MELSUNGEN AG: PRODUCT SEGMENTS
TABLE 97. B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
TABLE 98. B. BRAUN MELSUNGEN AG: KEY STRATERGIES
TABLE 99. ASAHI KASEI CORPORATION.: KEY EXECUTIVES
TABLE 100. ASAHI KASEI CORPORATION.: COMPANY SNAPSHOT
TABLE 101. ASAHI KASEI CORPORATION.: PRODUCT SEGMENTS
TABLE 102. ASAHI KASEI CORPORATION.: PRODUCT PORTFOLIO
TABLE 103. DAVITA INC.: KEY EXECUTIVES
TABLE 104. DAVITA INC.: COMPANY SNAPSHOT
TABLE 105. DAVITA INC.: SERVICE SEGMENTS
TABLE 106. DAVITA INC.: PRODUCT PORTFOLIO
TABLE 107. DAVITA INC.: KEY STRATERGIES
TABLE 108. NIKKISO CO., LTD: KEY EXECUTIVES
TABLE 109. NIKKISO CO., LTD: COMPANY SNAPSHOT
TABLE 110. NIKKISO CO., LTD: PRODUCT SEGMENTS
TABLE 111. NIKKISO CO., LTD: PRODUCT PORTFOLIO
TABLE 112. NIPRO CORPORATION: KEY EXECUTIVES
TABLE 113. NIPRO CORPORATION: COMPANY SNAPSHOT
TABLE 114. NIPRO CORPORATION: PRODUCT SEGMENTS
TABLE 115. NIPRO CORPORATION: PRODUCT PORTFOLIO
TABLE 116. NIPRO CORPORATION: KEY STRATERGIES
TABLE 117. FRESENIUS MEDICAL CARE AG & CO. KGAA: KEY EXECUTIVES
TABLE 118. FRESENIUS MEDICAL CARE AG & CO. KGAA: COMPANY SNAPSHOT
TABLE 119. FRESENIUS MEDICAL CARE AG & CO. KGAA: PRODUCT SEGMENTS
TABLE 120. FRESENIUS MEDICAL CARE AG & CO. KGAA: PRODUCT PORTFOLIO
TABLE 121. FRESENIUS MEDICAL CARE AG & CO. KGAA: KEY STRATERGIES
TABLE 122. DIAVERUM HOLDING AB: KEY EXECUTIVES
TABLE 123. DIAVERUM HOLDING AB: COMPANY SNAPSHOT
TABLE 124. DIAVERUM HOLDING AB: PRODUCT SEGMENTS
TABLE 125. DIAVERUM HOLDING AB: PRODUCT PORTFOLIO
TABLE 126. DIAVERUM HOLDING AB: KEY STRATERGIES
TABLE 127. ROCKWELL MEDICAL TECHNOLOGIES INC.: KEY EXECUTIVES
TABLE 128. ROCKWELL MEDICAL TECHNOLOGIES INC.: COMPANY SNAPSHOT
TABLE 129. ROCKWELL MEDICAL TECHNOLOGIES INC.: PRODUCT SEGMENTS
TABLE 130. ROCKWELL MEDICAL TECHNOLOGIES INC.: SERVICE SEGMENTS
TABLE 131. ROCKWELL MEDICAL TECHNOLOGIES INC.: PRODUCT PORTFOLIO
TABLE 132. ROCKWELL MEDICAL TECHNOLOGIES INC.: KEY STRATERGIES
TABLE 133. TORAY INDUSTRIES, INC.: KEY EXECUTIVES
TABLE 134. TORAY INDUSTRIES, INC.: COMPANY SNAPSHOT
TABLE 135. TORAY INDUSTRIES, INC.: PRODUCT SEGMENTS
TABLE 136. TORAY INDUSTRIES, INC.: PRODUCT PORTFOLIO
TABLE 137. TORAY INDUSTRIES, INC.: KEY STRATERGIES
LIST OF FIGURES
FIGURE 01. HEMODIALYSIS MARKET, 2022-2032
FIGURE 02. SEGMENTATION OF HEMODIALYSIS MARKET,2022-2032
FIGURE 03. TOP IMPACTING FACTORS IN HEMODIALYSIS MARKET (2022 TO 2032)
FIGURE 04. TOP INVESTMENT POCKETS IN HEMODIALYSIS MARKET (2023-2032)
FIGURE 05. LOW BARGAINING POWER OF SUPPLIERS
FIGURE 06. LOW THREAT OF NEW ENTRANTS
FIGURE 07. LOW THREAT OF SUBSTITUTES
FIGURE 08. LOW INTENSITY OF RIVALRY
FIGURE 09. LOW BARGAINING POWER OF BUYERS
FIGURE 10. GLOBAL HEMODIALYSIS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 11. HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2022 AND 2032(%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF HEMODIALYSIS MARKET FOR EQUIPMENTS, BY COUNTRY 2022 AND 2032(%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF HEMODIALYSIS MARKET FOR CONSUMABLES, BY COUNTRY 2022 AND 2032(%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF HEMODIALYSIS MARKET FOR DRUGS, BY COUNTRY 2022 AND 2032(%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF HEMODIALYSIS MARKET FOR SERVICES, BY COUNTRY 2022 AND 2032(%)
FIGURE 16. HEMODIALYSIS MARKET, BY TYPE, 2022 AND 2032(%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF HEMODIALYSIS MARKET FOR CONVENTIONAL HEMODIALYSIS, BY COUNTRY 2022 AND 2032(%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF HEMODIALYSIS MARKET FOR DAILY HEMODIALYSIS, BY COUNTRY 2022 AND 2032(%)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF HEMODIALYSIS MARKET FOR NOCTURNAL HEMODIALYSIS, BY COUNTRY 2022 AND 2032(%)
FIGURE 20. HEMODIALYSIS MARKET, BY DIALYSIS SITE, 2022 AND 2032(%)
FIGURE 21. COMPARATIVE SHARE ANALYSIS OF HEMODIALYSIS MARKET FOR IN-CENTER DIALYSIS, BY COUNTRY 2022 AND 2032(%)
FIGURE 22. COMPARATIVE SHARE ANALYSIS OF HEMODIALYSIS MARKET FOR HOME DIALYSIS, BY COUNTRY 2022 AND 2032(%)
FIGURE 23. HEMODIALYSIS MARKET BY REGION, 2022 AND 2032(%)
FIGURE 24. U.S. HEMODIALYSIS MARKET, 2022-2032 ($MILLION)
FIGURE 25. CANADA HEMODIALYSIS MARKET, 2022-2032 ($MILLION)
FIGURE 26. MEXICO HEMODIALYSIS MARKET, 2022-2032 ($MILLION)
FIGURE 27. GERMANY HEMODIALYSIS MARKET, 2022-2032 ($MILLION)
FIGURE 28. FRANCE HEMODIALYSIS MARKET, 2022-2032 ($MILLION)
FIGURE 29. UK HEMODIALYSIS MARKET, 2022-2032 ($MILLION)
FIGURE 30. ITALY HEMODIALYSIS MARKET, 2022-2032 ($MILLION)
FIGURE 31. SPAIN HEMODIALYSIS MARKET, 2022-2032 ($MILLION)
FIGURE 32. REST OF EUROPE HEMODIALYSIS MARKET, 2022-2032 ($MILLION)
FIGURE 33. JAPAN HEMODIALYSIS MARKET, 2022-2032 ($MILLION)
FIGURE 34. CHINA HEMODIALYSIS MARKET, 2022-2032 ($MILLION)
FIGURE 35. AUSTRALIA HEMODIALYSIS MARKET, 2022-2032 ($MILLION)
FIGURE 36. INDIA HEMODIALYSIS MARKET, 2022-2032 ($MILLION)
FIGURE 37. SOUTH KOREA HEMODIALYSIS MARKET, 2022-2032 ($MILLION)
FIGURE 38. REST OF ASIA-PACIFIC HEMODIALYSIS MARKET, 2022-2032 ($MILLION)
FIGURE 39. BRAZIL HEMODIALYSIS MARKET, 2022-2032 ($MILLION)
FIGURE 40. SAUDI ARABIA HEMODIALYSIS MARKET, 2022-2032 ($MILLION)
FIGURE 41. SOUTH AFRICA HEMODIALYSIS MARKET, 2022-2032 ($MILLION)
FIGURE 42. REST OF LAMEA HEMODIALYSIS MARKET, 2022-2032 ($MILLION)
FIGURE 43. TOP WINNING STRATEGIES, BY YEAR (2020-2023)
FIGURE 44. TOP WINNING STRATEGIES, BY DEVELOPMENT (2020-2023)
FIGURE 45. TOP WINNING STRATEGIES, BY COMPANY (2020-2023)
FIGURE 46. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 47. COMPETITIVE DASHBOARD
FIGURE 48. COMPETITIVE HEATMAP: HEMODIALYSIS MARKET
FIGURE 49. TOP PLAYER POSITIONING, 2022
FIGURE 50. BAXTER INTERNATIONAL INC.: NET SALES, 2020-2022 ($MILLION)
FIGURE 51. BAXTER INTERNATIONAL INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 52. BAXTER INTERNATIONAL INC.: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 53. B. BRAUN MELSUNGEN AG: NET SALES, 2020-2022 ($MILLION)
FIGURE 54. B. BRAUN MELSUNGEN AG: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 55. B. BRAUN MELSUNGEN AG: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 56. ASAHI KASEI CORPORATION.: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 57. ASAHI KASEI CORPORATION.: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 58. DAVITA INC.: SALES REVENUE, 2020-2022 ($BILLION)
FIGURE 59. DAVITA INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 60. NIKKISO CO., LTD: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 61. NIKKISO CO., LTD: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 62. NIKKISO CO., LTD: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 63. NIPRO CORPORATION: NET SALES, 2020-2022 ($MILLION)
FIGURE 64. NIPRO CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 65. NIPRO CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 66. FRESENIUS MEDICAL CARE AG & CO. KGAA: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 67. FRESENIUS MEDICAL CARE AG & CO. KGAA: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 68. ROCKWELL MEDICAL TECHNOLOGIES INC.: NET SALES, 2020-2022 ($MILLION)
FIGURE 69. ROCKWELL MEDICAL TECHNOLOGIES INC.: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 70. TORAY INDUSTRIES, INC.: NET SALES, 2020-2022 ($MILLION)
FIGURE 71. TORAY INDUSTRIES, INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 72. TORAY INDUSTRIES, INC.: REVENUE SHARE BY REGION, 2022 (%)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings